Last reviewed · How we verify

Galeno Desenvolvimento de Pesquisas Clínicas — Portfolio Competitive Intelligence Brief

Galeno Desenvolvimento de Pesquisas Clínicas pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Lidocaine + Prilocaine Lidocaine + Prilocaine marketed Local anesthetic Voltage-gated sodium channels Anesthesia/Pain Management
ethinyl estradiol + levonorgestrel + folic acid ethinyl estradiol + levonorgestrel + folic acid phase 3 Oral contraceptive with folic acid supplementation Progesterone receptor, estrogen receptor Contraception / Women's Health

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Ain Shams Maternity Hospital · 1 shared drug class
  2. Ain Shams University · 1 shared drug class
  3. Aligarh Muslim University · 1 shared drug class
  4. Atlantic Health System · 1 shared drug class
  5. Aultman Health Foundation · 1 shared drug class
  6. B.P. Koirala Institute of Health Sciences · 1 shared drug class
  7. Bagcilar Training and Research Hospital · 1 shared drug class
  8. Abant Izzet Baysal University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Galeno Desenvolvimento de Pesquisas Clínicas:

Cite this brief

Drug Landscape (2026). Galeno Desenvolvimento de Pesquisas Clínicas — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/galeno-desenvolvimento-de-pesquisas-cl-nicas. Accessed 2026-05-18.

Related